SARS-CoV-2-associated myositis

Authors:

Moreno Sánchez A^a, Molina Herranz D^b, Salinas Salvador B^c, Gómez Barrena V^d, Beltrán García S^e, Sáez de Adana Pérez ME^f

^aMIR-Pediatría. Hospital Universitario Miguel Servet. Zaragoza, España.
^bMIR-Pediatría. Hospital Universitario Miguel Servet. Zaragoza, España.
^cMIR-Pediatría. Hospital Universitario Miguel Servet. Zaragoza, España.
^dServicio de Pediatría. Hospital Universitario Miguel Servet. Zaragoza. España.
^ePediatra. CS Valdespartera. Zaragoza, España.
^fPediatra. CS Valdespartera-Montecanal. Zaragoza. España.

Correspondence: A Moreno . Email: ameliamorenosanchez111@gmail.com

Reference of this article.:

Moreno Sánchez A, Molina Herranz D, Salinas Salvador B, Gómez Barrena V, Beltrán García S, Sáez de Adana Pérez ME. Miositis por SARS-CoV-2 . Rev Pediatr Aten Primaria. 2022;24:e323-e325..

Published in Internet: 11/10/2022

Abstract:

We describe the case of a 9-year-old patient who presented with inability to walk due to lower extremity pain in the follow-up of infection by SARS-CoV-2. Since the manifestations and findings of the examination were compatible with myositis, a blood test was performed that evinced elevation of creatine phosphokinase. The patient had a favourable outcome with symptomatic treatment. In the context of this case, we conducted a literature review of paediatric cases of myositis associated with SARS-CoV-2 infection.

Keywords: SARS-CoV-2. COVID-19. Myositis.